Top Story

Effective implementation of nine-valent HPV vaccination could prevent majority of cervical cancers

October 1, 2014

Most cervical precancers appear to be caused by one of nine types of HPV, according to study results.

The findings suggest an investigational nine-valent HPV vaccine — manufactured by Merck and currently under review by the FDA — could prevent cervical cancers more effectively than current vaccines, according to study results.

figure

First Ebola case diagnosed in US

September 30, 2014
The CDC today confirmed that a man in Texas who recently returned from West Africa was diagnosed in the United States with Ebola virus. The unidentified patient left…
figure

Medical societies express concern as CMS publishes first wave of payment data

September 30, 2014
CMS has come under criticism today for the release of its first batch of Open Payments System data. According to some medical societies, the data are inaccurate and…

NIH, FDA win award for meningitis vaccine licensing deal

September 30, 2014
The technology transfer of a low-cost meningitis vaccine earned the NIH and FDA an award for the year’s most outstanding intellectual property licensing deal…
More News Headlines »
Health Care Legislative and Regulatory Update
figure

The Sunshine Act and CME-related payments

Spine Surgery Today, September/October 2014
Abraham Gitterman; Marilyn May, JD
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and…
More »
Blog

Potential novel biomarker identified for bacterial pneumonia

June 4, 2014
In the June 15th 2014 issue of Clinical Infectious Diseases, Huang and colleagues identified and validated a novel…
More »
Meeting News Coverage Video
figure

Experts debate PANDAS diagnosis in children

September 18, 2014
WASHINGTON, D.C. — Margaret K. Hostetter, MD, the B. K. Rachford professor and chair of department of…
More »